Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mycotopia Therapies Inc (OP: TPIA ) 0.0291 UNCHANGED Last Price Updated: 2:35 PM EDT, Aug 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.0291 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0291 Today's Range 0.0291 - 0.0291 52wk Range 0.0130 - 0.1799 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company May 24, 2022 Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. Via Benzinga Ehave's Mycotopia Therapies To Merge With Ei.Ventures To Form PSLY.COM May 23, 2022 Mycotopia Therapies (OTCPK:TPIA) subsidiary of Ehave, Inc. (OTCPK:EHVVF), has signed a definitive agreement to complete a triangular merger with Ei.Ventures, to form PSLY.COM. The companies anticipate... Via Benzinga Performance YTD +81.88% +81.88% 1 Month -3.00% -3.00% 3 Month -3.00% -3.00% 6 Month +120.45% +120.45% 1 Year -41.80% -41.80% More News Read More Ei.Ventures And Mycotopia To Merge Into New Psychedelic Mushroom Company May 20, 2022 Via Benzinga Mycotopia Therapies Expands Supply Agreement With HAVN Life Sciences To Include Functional Mushrooms & Other Products March 21, 2022 Via Benzinga Psychedelic Medicine Is On The Rise And Retail Investors Can Own A Piece Of This Groundbreaking Company March 15, 2022 Via Benzinga Could Mushrooms Treat Mental Health Disorders? This Company Thinks It Found the Key And Retail Investors Can Help March 15, 2022 Via Benzinga Psychedelics Stock Mycotopia Plunges On LOI To Merge With Ei.Ventures, A $360M Transaction December 08, 2021 Via Benzinga Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold August 30, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.